Koniari Ioanna, Gerakaris Andreas, Kounis Nicholas, Velissaris Dimitrios, Rao Archana, Ainslie Mark, Adlan Ahmed, Plotas Panagiotis, Ikonomidis Ignatios, Mplani Virginia, Hung Ming-Yow, de Gregorio Cesare, Kolettis Theofilos, Gupta Dhiraj
Department of Electrophysiology, Liverpool Heart and Chest Hospital, Liverpool L14 3PE, UK.
Department of Internal Medicine, University Hospital of Patras, 26500 Patras, Greece.
J Cardiovasc Dev Dis. 2023 Jun 26;10(7):272. doi: 10.3390/jcdd10070272.
To review the relevant literature on the use of atrioventricular node ablation and pacing in patients with heart failure and atrial fibrillation. APubMed/MEDLINE and SCOPUS search was performed in order to assess the clinical outcomes of atrioventricular node ablation and pacemaker implantation, as well as the complications that may occur. Several clinical trials, observational analyses and meta-analyses have shown that the "pace and ablate" strategy not only improves symptoms but also can enhance cardiac performance in patients with heart failure and atrial fibrillation. Although this procedure is effective and safe, some complications may occur including worsening of heart failure, permanent fibrillation, arrhythmias and sudden death. Regarding pacemaker implantation, cardiac resynchronization therapy is shown to be the optimal choice compared to right ventricle apical pacing. His bundle pacing is a promising alternative to cardiac resynchronization therapy and has shown beneficial effects, while left bundle branch pacing is an innovative modality. Atrioventricular node ablation and pacemaker implantation is shown to have beneficial effects on clinical outcomes of patients with atrial fibrillation ± heart failure who do not respond or are intolerant to medical treatment. Cardiac resynchronization therapy is the treatment of choice and His bundle pacing seems to be an effective alternative way of pacing in these patients.
回顾关于心力衰竭合并心房颤动患者应用房室结消融和起搏治疗的相关文献。通过PubMed/MEDLINE和SCOPUS检索,以评估房室结消融和起搏器植入的临床结局以及可能发生的并发症。多项临床试验、观察性分析和荟萃分析表明,“起搏并消融”策略不仅能改善症状,还可增强心力衰竭合并心房颤动患者的心脏功能。尽管该手术有效且安全,但可能会出现一些并发症,包括心力衰竭恶化、持续性房颤、心律失常和猝死。关于起搏器植入,与右心室心尖部起搏相比,心脏再同步治疗被证明是最佳选择。希氏束起搏是心脏再同步治疗的一种有前景的替代方法,并已显示出有益效果,而左束支起搏是一种创新方式。房室结消融和起搏器植入对药物治疗无效或不耐受的心房颤动±心力衰竭患者的临床结局具有有益影响。心脏再同步治疗是首选治疗方法,希氏束起搏似乎是这些患者有效的替代起搏方式。